XML 71 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Taxes
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Taxes

Note 7. Taxes

Biomea Fusion is subject to U.S. federal and state income taxes as a corporation. Prior to the tax-free reorganization in December 2020, Biomea Fusion, LLC was treated as a pass-through entity for U.S. federal income tax purposes, and as such, was generally not subject to U.S. federal income tax at the entity level. Rather, the tax liability with respect to its taxable income, was passed through to its unitholders.

There was zero income tax expense for the years ended December 31, 2022, 2021 and 2020. The following is a reconciliation of the statutory federal income tax rate to the Company’s effective tax rate:

 

 

Year Ended December 31,

 

 

2022

 

 

2021

 

 

2020

 

Federal statutory income tax rate

 

21.0

%

 

 

21.0

%

 

 

21.0

%

State income tax rate

 

0.5

%

 

 

0.5

%

 

 

1.1

%

Tax credits

 

1.1

%

 

 

0.2

%

 

 

 

Stock-based compensation

 

(1.1

)%

 

 

(1.5

)%

 

 

 

Amortization

 

 

 

 

2.6

%

 

 

 

LLC loss prior to C-Corp conversion

 

 

 

 

 

 

 

(17.7

)%

Change in valuation allowance

 

(21.5

)%

 

 

(22.7

)%

 

 

(4.3

)%

Other

 

 

 

 

(0.1

)%

 

 

(0.1

)%

Effective income tax rate

 

0.0

%

 

 

0.0

%

 

 

0.0

%

 

Deferred tax assets and liabilities consist of the following (in thousands):

 

 

December 31,

 

 

2022

 

 

2021

 

Deferred tax assets:

 

 

 

 

 

Net operating loss carryforwards

$

12,100

 

 

$

7,689

 

Capitalized research and development

 

10,326

 

 

 

 

Accrued liabilities and reserves

 

411

 

 

 

65

 

Stock-based compensation

 

1,887

 

 

 

675

 

Intangible assets

 

1,129

 

 

 

1,044

 

Operating lease liabilities

 

480

 

 

 

599

 

Research and development credits

 

1,633

 

 

 

278

 

Property and equipment

 

 

 

 

 

Gross deferred tax assets

 

27,966

 

 

 

10,350

 

Valuation allowance

 

(27,432

)

 

 

(9,730

)

Total deferred tax assets

 

534

 

 

 

620

 

Deferred tax liabilities:

 

 

 

 

 

Property and equipment

 

(82

)

 

 

(48

)

Operating lease right-of-use assets

 

(452

)

 

 

(572

)

Total deferred tax liabilities

 

(534

)

 

 

(620

)

Net deferred tax assets

$

 

 

$

 

 

The provisions of ASC Topic 740, Accounting for Income Taxes (ASC 740), require an assessment of both positive and negative evidence when determining whether it is more likely than not that deferred tax assets are recoverable. For the years ended December 31, 2022 and 2021, based on all available objective evidence, including the existence of cumulative losses,

the Company determined that it was not more likely than not that the net deferred tax assets were fully realizable. Accordingly, the Company established a full valuation allowance against its deferred tax assets. The Company intends to maintain a full valuation allowance on net deferred tax assets until sufficient positive evidence exists to support reversal of the valuation allowance. The Company’s valuation allowance increased by $17.7 million during the year ended December 31, 2022, primarily because of an increase to the Company's net operating losses, credits, stock compensation, and the capitalization of research and development expenses. The Company’s valuation allowance increased by $9.4 million during the year ended December 31, 2021, primarily because of an increase to the Company's net operating loss deferred tax assets, credits and intangible deferred tax assets.

At December 31, 2022, the Company had net operating loss carryforwards available to reduce future taxable income, if any, for federal and state income tax purposes of approximately $57.2 million and $1.3 million, respectively. The federal net operating loss carryforwards at December 31, 2022 can be carried forward indefinitely, subject to an annual limitation of 80% of taxable income. The state net operating loss carryforward begins expiring in 2040.

At December 31, 2022, the Company also had federal and California research and development tax credit carryforwards of $1.3 million and $1.1 million, respectively, available to offset future income tax, if any. The federal credit carryforwards begins expiring in 2040, and the California credits can be carried forward indefinitely.

Under Section 382 and 383 of the Internal Revenue Code of 1986, as amended, if a corporation undergoes an “ownership change,” the corporation's ability to use its pre-change net operating loss carryforwards and other pre-change attributes, such as research tax credits, to offset its post-change income may be limited. In general, an “ownership change” will occur if there is a cumulative change in the Company's ownership by “5-percent shareholders” that exceeds 50 percentage points over a rolling three-year period. Similar rules may apply under state tax laws. Therefore, certain of the Company's carryforward tax attributes may be subject to an annual limitation regarding their utilization against taxable income in future periods. The Company has performed a Section 382 study and has concluded that ownership changes have occurred. As a result, the federal and state NOL carryforwards and tax credit carryforwards maybe subject to annual limitations before being applied to reduce future income tax liabilities.

Uncertain Tax Positions

The Company adopted the provisions of ASC 740, which requires companies to determine whether it is “more likely than not” that a tax position will be sustained upon examination by the appropriate taxing authorities before any tax benefit can be recorded in the financial statements. It also provides guidance on the recognition, measurement, classification and interest and penalties related to uncertain tax positions.

The following table summarizes the activity related to the Company’s gross unrecognized tax benefits (in thousands):

 

 

Year Ended December 31,

 

 

2022

 

 

2021

 

 

2020

 

Beginning balance

$

112

 

 

$

 

 

$

 

Increases for tax provisions related to prior year

 

133

 

 

 

1

 

 

 

 

Increases for tax provisions related to current year

 

379

 

 

 

111

 

 

 

 

Ending balance

$

624

 

 

$

112

 

 

$

 

The unrecognized tax benefits, if recognized, would not affect the effective income tax rate due to the valuation allowance that currently offsets deferred tax assets. Interest and penalties were zero. The Company does not expect the unrecognized tax benefits to change significantly over the next twelve months.

The Company files federal and state income tax returns. All periods since inception are subject to examination by federal and state authorities, where applicable. There are currently no pending income tax examinations.